Swedbank AB Raises Stock Position in Corteva, Inc. $CTVA

Swedbank AB boosted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 17.3% in the first quarter, HoldingsChannel reports. The firm owned 2,227,017 shares of the company’s stock after buying an additional 328,282 shares during the period. Swedbank AB’s holdings in Corteva were worth $186,424,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in CTVA. William B. Walkup & Associates Inc. grew its position in Corteva by 2.9% during the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock worth $373,000 after purchasing an additional 126 shares during the period. AdvisorNet Financial Inc boosted its stake in shares of Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after buying an additional 135 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC boosted its stake in shares of Corteva by 9.1% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock worth $112,000 after buying an additional 140 shares during the last quarter. Eagle Bay Advisors LLC grew its holdings in Corteva by 4.3% during the first quarter. Eagle Bay Advisors LLC now owns 3,721 shares of the company’s stock worth $312,000 after acquiring an additional 153 shares during the period. Finally, Tred Avon Family Wealth LLC grew its holdings in Corteva by 2.5% during the first quarter. Tred Avon Family Wealth LLC now owns 6,248 shares of the company’s stock worth $523,000 after acquiring an additional 154 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Price Performance

Corteva stock traded up $0.34 during midday trading on Tuesday, reaching $86.72. The company had a trading volume of 535,288 shares, compared to its average volume of 4,018,642. The company has a market capitalization of $58.00 billion, a P/E ratio of 51.01, a P/E/G ratio of 2.62 and a beta of 0.56. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $87.69. The firm’s fifty day simple moving average is $79.80 and its 200-day simple moving average is $76.94. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period in the previous year, the business earned $1.13 EPS. Corteva’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s payout ratio is presently 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of analyst reports. Argus boosted their price target on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Wells Fargo & Company raised their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. Mizuho lifted their target price on shares of Corteva from $94.00 to $96.00 and gave the company an “outperform” rating in a report on Thursday, July 2nd. Citigroup boosted their target price on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Finally, Barclays increased their price target on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $88.90.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.